Transcutaneous Bilirubin Levels From Covered Skin
Conditions: Hyperbilirubinemia, Neonatal Interventions: Device: covered or open skin Sponsors: Ankara Training and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds
Conditions: Wound Heal Interventions: Device: Hyalo4 Skin Gel Sponsors: Fidia Farmaceutici s.p.a. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Measure of Acceptance of chRonic Visible sKin conditionS
Conditions: Acceptance of Visible Chronic Dermatological Disease; Disease Acceptance; Psychological Well-Being; Social Segregation Interventions: Behavioral: Questionnaire Sponsors: University Hospital, Tours; INSERM UMR 1246 SPHERE Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Genetic Susceptibility to Severe Infections
Conditions: Infectious Disease Interventions: Other: Blood samples drawing; Other: Skin biopsy Sponsors: Institut National de la Sant é Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Use of Continence Care Protocol in UK Nursing Homes.
Conditions: Urinary Incontinence Due to Cognitive Impairment; Urinary Incontinence Interventions: Other: Skin and leakage protocol Sponsors: Essity Hygiene and Health AB; Lincolnshire Community Health Services NHS Trust Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin
Conditions: Photoaging Interventions: Other: Topical Vehicle + Zinc Di-(dibutyryl lisinate); Other: Topical Vehicle Sponsors: Integrative Skin Science and Research; Sytheon Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
RCT of an Oral Acne Supplement for Adult Women
Conditions: Acne Interventions: Dietary Supplement: Skin Nutraceutical Supplement; Other: Placebo pill Sponsors: Nutraceutical Wellness Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc)
Conditions: Dysbiosis; Catheter-Related Infections Interventions: Diagnostic Test: Skin swabbing; Other: Data collection Sponsors: Centre Hospitalier de Cayenne; Tropical Biome and ImmunoPhysiopathology (TBIP) - French Guiana University (Universit é de Guyane) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Swelling Management After Total Knee Arthroplasty: A Randomized Controlled Trial
Conditions: Arthroplasties, Knee Replacement Interventions: Other: Inelastic adjustable compression garment (INCOM); Other: Elastic compression garment (CONTROL) Sponsors: University of Colorado, Denver; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Swelling Management After Knee Replacement
Conditions: Arthroplasties, Knee Replacement Interventions: Other: Inelastic adjustable compression garment (INCOM); Other: Elastic compression garment (CONTROL) Sponsors: University of Colorado, Denver; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial
DiscussionThe present trial will be the first to evaluate the effect of LLTS on frequent PVCs on patients without SHD. LLTS may serve as a low-cost, minimal-risk, and non-invasive alternative to conventional antiarrhythmic therapy.Trial registrationClinicalTrial.gov NCT04909528. Registered on 17 June 2021. World health organization trial registration data set was shown in Supplementary Table1. (Source: Trials)
Source: Trials - October 23, 2023 Category: Research Source Type: clinical trials
Studying Melatonin and Recovery in Teens
Conditions: Juvenile; Scoliosis; Scoliosis Idiopathic; Scoliosis; Adolescence; Scoliosis;Congenital; Kyphosis; Spondylolisthesis Interventions: Dietary Supplement: Melatonin; Other: Syrup Sponsors: Stanford University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Digital Versus Telephone Symptom Assessment and Triage in Primary Care
Conditions: Infections; Injuries; Psychiatric Disorder; Gastro-Intestinal Disorder; Skin Diseases Interventions: Behavioral: Digital triage Sponsors: Region Skane Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Nearly 80% of Patients with Moderate-to-Severe Atopic Dermatitis Maintained Clear or Almost Clear Skin with Lilly's Lebrikizumab Monthly Maintenance Dosing at Two Years
INDIANAPOLIS, Oct. 20, 2023 /PRNewswire/ -- Patients with moderate-to-severe atopic dermatitis who continued treatment with investigational lebrikizumab for up to two years experienced sustained skin clearance, itch relief and reduced disease... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 20, 2023 Category: Pharmaceuticals Source Type: clinical trials
Combining Broad Based Light, Fractionated 1927 and Dual Wavelength 2940/1470 for Diffuse Pigmentation, Texture and Actinic Changes
Conditions: Pigment Skin Interventions: Device: Sciton Joule System Sponsors: University of Texas Southwestern Medical Center; Sciton Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
